{"id":879777,"date":"2025-08-27T17:24:50","date_gmt":"2025-08-27T21:24:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/"},"modified":"2025-08-27T17:24:50","modified_gmt":"2025-08-27T21:24:50","slug":"adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/","title":{"rendered":"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SEATTLE, Aug.  27, 2025  (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Morgan Stanley 23<sup>rd<\/sup> Annual Global Healthcare Conference in New York, NY.<\/p>\n<p align=\"justify\">Adaptive Biotechnologies\u2019 management is scheduled to participate in a fireside chat on Wednesday, September 10<sup>th<\/sup> at 10:05 a.m. Pacific Time \/ 1:05 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the \u201cInvestors\u201d section of the company website at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gJWGeVuG7SUP1UHnGM0vmbPLb9pY2SnVR3Ino7kmnv9nwt8biJJJ0ABFTSeVzUbXrBDD389PVro33jHnmIf4Wd8xYaEw4YMUhLZh1gZ6KHU=\" rel=\"nofollow\" target=\"_blank\">www.adaptivebiotech.com<\/a>.<\/p>\n<p>\n        <strong>About Adaptive Biotechnologies<\/strong>\n      <\/p>\n<p>Adaptive Biotechnologies (\u201cwe\u201d or \u201cour\u201d) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature\u2019s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business segments: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer and autoimmune disorders. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.<\/p>\n<p>\n        <strong>ADAPTIVE INVESTORS<\/strong><br \/>\n        <br \/>Karina Calzadilla, Vice President, Investor Relations and FP&amp;A<br \/>201-396-1687<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N0ErznNzJwIOyiRGcd2n4DBm3uYzEu29ss4nhXv6L4Cx9xb7f--ht58UtcakUDyM_H7wsoR3gr6gcNSuAq0asc6CebgZnMXPhwkEMt1CzgnITOXil3z97gh2We3xT6n-\" rel=\"nofollow\" target=\"_blank\">investors@adaptivebiotech.com<\/a><\/p>\n<p>\n        <strong>ADAPTIVE MEDIA<\/strong><br \/>\n        <br \/>Erica Jones, Associate Corporate Communications Director<br \/>206-279-2423<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5O8F7-VQgXemfBGnN_U-zdG1TTO9SEpNZa0wFwksDOKl4AoXCMkgXIubtJmw5zpXoS-ukrNS1mNik75JFDhoRbEWaxO4_wUCJbpFCBAyhNT0aDv9N5rWziLKpfRzZIwS\" rel=\"nofollow\" target=\"_blank\">media@adaptivebiotech.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZmMwNDM5YzgtMTUzOS00NDY1LTkyMTctODdkYWZmYTU2OGUwLTExODg3NTItMjAyNS0wOC0yNy1lbg==\/tiny\/Adaptive-Biotechnologies.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. Adaptive Biotechnologies\u2019 management is scheduled to participate in a fireside chat on Wednesday, September 10th at 10:05 a.m. Pacific Time \/ 1:05 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the \u201cInvestors\u201d section of the company website at: www.adaptivebiotech.com. About Adaptive Biotechnologies Adaptive Biotechnologies (\u201cwe\u201d or \u201cour\u201d) is a commercial-stage biotechnology company focused on harnessing the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-879777","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. Adaptive Biotechnologies\u2019 management is scheduled to participate in a fireside chat on Wednesday, September 10th at 10:05 a.m. Pacific Time \/ 1:05 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the \u201cInvestors\u201d section of the company website at: www.adaptivebiotech.com. About Adaptive Biotechnologies Adaptive Biotechnologies (\u201cwe\u201d or \u201cour\u201d) is a commercial-stage biotechnology company focused on harnessing the &hellip; Continue reading &quot;Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-27T21:24:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference\",\"datePublished\":\"2025-08-27T21:24:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/\",\"name\":\"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI=\",\"datePublished\":\"2025-08-27T21:24:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Market Newsdesk","og_description":"SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) &#8212; Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. Adaptive Biotechnologies\u2019 management is scheduled to participate in a fireside chat on Wednesday, September 10th at 10:05 a.m. Pacific Time \/ 1:05 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the \u201cInvestors\u201d section of the company website at: www.adaptivebiotech.com. About Adaptive Biotechnologies Adaptive Biotechnologies (\u201cwe\u201d or \u201cour\u201d) is a commercial-stage biotechnology company focused on harnessing the &hellip; Continue reading \"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-27T21:24:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference","datePublished":"2025-08-27T21:24:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/","name":"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI=","datePublished":"2025-08-27T21:24:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNjg2NSM3MTExOTg5IzIxNzcxODI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/879777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=879777"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/879777\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=879777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=879777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=879777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}